✦ LIBER ✦
A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice
✍ Scribed by Yutaka Kimura; Nobuteru Kikkawa; Shohei Iijima; Takeshi Kato; Yasuto Naoi; Taro Hayashi; Takahiko Tanigawa; Hitoshi Yamamoto; Eiji Kurokawa
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 147 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1436-3291
No coin nor oath required. For personal study only.